Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

PADI4 Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA522317

Catalog No. PIPA522317


Add to cart

Description

Description

PA5-22317 targets PAD4 in ICC, IF, IHC (P), and WB applications and shows reactivity with Human samples. The PA5-22317 immunogen is a recombit fragment corresponding to a region within amino acids 326 and 611 of PAD4 (Uniprot IDNo.Q9UM07). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial. For short-term storage (1-2 weeks), product can be stored at 4°C. For long-term storage, aliquot and store product at -20° C or below, avioiding multiple freeze-thaw cycles.

Specifications

Specifications

PADI4
Polyclonal
Unconjugated
PADI4
Liquid
PADI4
Recombit fragment corresponding to a region within amino acids 326 and 611 of PAD4 (Uniprot IDNo.Q9UM07)
Antigen affinity chromatography
RUO
Antibody
Polyclonal
Human
ChIP assay, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
0.44 mg/mL
PBS with 1% BSA, 20% glycerol and 0.025% Proclin 300
Q9UM07
PAD, PAD4, PADI5, PDI4, PDI5, HL-60 PAD, PADI-H protein, peptidyl arginine deiminase, type V, protein-arginine deiminase type IV, protein-arginine deiminase type-4
Rabbit
IgG
100 μL
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Primary
23569
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit